PTC Therapeutics, Inc. PTCT
64.35 USD -0.56 (-0.86%)
Nov 12, 2026, 9:34 AM EST
63.70 Day range 64.86
58.80 52-week range 90.87
- YTD
- -15.28%
- 1 year
- -12.83%
PTCT revenue history
Revenue is income from the company’s ordinary business activities.
1,730,655,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 1,730,655,000 | 923,875,000 | 114.51% |
| FY 2024 | 2024-12-31 | 806,780,000 | -131,042,000 | -13.97% |
| FY 2023 | 2023-12-31 | 937,822,000 | 239,021,000 | 34.20% |
| FY 2022 | 2022-12-31 | 698,801,000 | 160,208,000 | 29.75% |
| FY 2021 | 2021-12-31 | 538,593,000 | 157,827,000 | 41.45% |
| FY 2020 | 2020-12-31 | 380,766,000 | 73,786,000 | 24.04% |
| FY 2019 | 2019-12-31 | 306,980,000 | 42,246,000 | 15.96% |
| FY 2018 | 2018-12-31 | 264,734,000 | 70,342,000 | 36.19% |
| FY 2017 | 2017-12-31 | 194,392,000 | 111,687,000 | 135.04% |
| FY 2016 | 2016-12-31 | 82,705,000 | 45,939,000 | 124.95% |
| FY 2015 | 2015-12-31 | 36,766,000 | 11,521,000 | 45.64% |
| FY 2014 | 2014-12-31 | 25,245,000 | -9,451,000 | -27.24% |
| FY 2013 | 2013-12-31 | 34,696,000 | 750,000 | 2.21% |
| FY 2012 | 2012-12-31 | 33,946,000 | -71,466,000 | -67.80% |
| FY 2011 | 2011-12-31 | 105,412,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-10-31T06:00:33.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.